» Articles » PMID: 35682720

Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles Throughout the Lifespan and Protects Against the Development of Adult NAFLD

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jun 10
PMID 35682720
Authors
Affiliations
Soon will be listed here.
Abstract

Maternal obesity and consumption of a high-fat diet significantly elevate risk for pediatric nonalcoholic fatty liver disease (NAFLD), affecting 10% of children in the US. Almost half of these children are diagnosed with nonalcoholic steatohepatitis (NASH), a leading etiology for liver transplant. Animal models show that signs of liver injury and perturbed lipid metabolism associated with NAFLD begin in utero; however, safe dietary therapeutics to blunt developmental programming of NAFLD are unavailable. Using a mouse model of maternal Western-style diet (WD), we previously showed that pyrroloquinoline quinone (PQQ), a potent dietary antioxidant, protected offspring of WD-fed dams from development of NAFLD and NASH. Here, we used untargeted mass spectrometry-based lipidomics to delineate lipotoxic effects of WD on offspring liver and identify lipid targets of PQQ. PQQ exposure during pregnancy altered hepatic lipid profiles of WD-exposed offspring, upregulating peroxisome proliferator-activated receptor (PPAR) α signaling and mitochondrial fatty acid oxidation to markedly attenuate triglyceride accumulation beginning in utero. Surprisingly, the abundance of very long-chain ceramides, important in promoting gut barrier and hepatic function, was significantly elevated in PQQ-treated offspring. PQQ exposure reduced the hepatic phosphatidylcholine/phosphatidylethanolamine (PC/PE) ratio in WD-fed offspring and improved glucose tolerance. Notably, levels of protective n - 3 polyunsaturated fatty acids (PUFAs) were elevated in offspring exposed to PQQ, beginning in utero, and the increase in n - 3 PUFAs persisted into adulthood. Our findings suggest that PQQ supplementation during gestation and lactation augments pathways involved in the biosynthesis of long-chain fatty acids and plays a unique role in modifying specific bioactive lipid species critical for protection against NAFLD risk in later life.

Citing Articles

Linking Circadian Rhythms to Gut-Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease.

Su J, Zhao L, Fu R, Tang Z CNS Neurosci Ther. 2025; 31(3):e70329.

PMID: 40059063 PMC: 11890981. DOI: 10.1111/cns.70329.


Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefits: PQQ: Human health impacts and benefits.

Yan T, Nisar M, Hu X, Chang J, Wang Y, Wu Y Curr Res Food Sci. 2024; 9:100889.

PMID: 39513102 PMC: 11541945. DOI: 10.1016/j.crfs.2024.100889.


Pyrroloquinoline-quinone to reduce fat accumulation and ameliorate obesity progression.

Ishak N, Ikemoto K Front Mol Biosci. 2023; 10:1200025.

PMID: 37214340 PMC: 10196175. DOI: 10.3389/fmolb.2023.1200025.


Association between Dietary Pattern, Nutritional Status, Metabolic Factors, and Nonalcoholic Fatty Liver Disease.

Xing G, Huang Y, Liu X Contrast Media Mol Imaging. 2022; 2022:4157403.

PMID: 35992537 PMC: 9363176. DOI: 10.1155/2022/4157403.


Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0.

Vairetti M, Colucci G, Ferrigno A Int J Mol Sci. 2022; 23(14).

PMID: 35887242 PMC: 9319880. DOI: 10.3390/ijms23147894.

References
1.
Jonscher K, Chowanadisai W, Rucker R . Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention. Biomolecules. 2021; 11(10). PMC: 8533503. DOI: 10.3390/biom11101441. View

2.
Bauerly K, Harris C, Chowanadisai W, Graham J, Havel P, Tchaparian E . Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLoS One. 2011; 6(7):e21779. PMC: 3140972. DOI: 10.1371/journal.pone.0021779. View

3.
Ren C, Hou L, Liu B, Yang G, Wang Y, Shi Q . Distinct structures of coordination polymers incorporating flexible triazole-based ligand: topological diversities, crystal structures and property studies. Dalton Trans. 2010; 40(4):793-804. DOI: 10.1039/c0dt00894j. View

4.
Matteoni C, Younossi Z, Gramlich T, Boparai N, Liu Y, McCullough A . Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116(6):1413-9. DOI: 10.1016/s0016-5085(99)70506-8. View

5.
Jelenik T, Kaul K, Sequaris G, Flogel U, Phielix E, Kotzka J . Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. Diabetes. 2017; 66(8):2241-2253. PMC: 5521856. DOI: 10.2337/db16-1147. View